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Abstract
Introduction: We aimed to compare the outcomes of robotic laparoendoscopic single-site living donor nephrectomy (R-LESS LDN)
vs. standard laparoscopic living donor nephrectomy (LLDN).
Methods: Between October 2013 and November 2015, 39 patients
were allocated to either standard LLDN (n=25) or R-LESS LDN
(n=14). Patient demographics, perioperative outcomes, analgesic
requirement, visual analogue scale of pain at postoperative days 1,
3, 7, and 30, and a health-related quality of life and body image
questionnaire were prospectively collected.
Results: There were no significant differences in demographics
and intraoperative outcomes between the two cohorts. The R-LESS
LDN cohort had lower analgesic requirement (p=0.002) and lower
visual pain scores on days 1 and 3 (p=0.001). Additionally, body
image and satisfaction scores in the R-LESS group were also superior compared to the LLDN cohort (p=0.008). There was no significant difference in the postoperative complications according
to the Clavien-Dindo system. Recipient graft functional outcomes
were equivalent.
Conclusions: This is the first evidence that R-LESS LDN is safe and
associated with comparable surgical and early functional outcomes
compared to LLDN, while pain, donor body image, and satisfaction
scores were improved compared to LLDN.

Introduction
Kidney transplantation is the preferred option for patients
with end-stage renal disease. However, due to shortage of
donor organs, we turn to living donor kidney transplants,
which provide better graft function and survival compared
to organs from deceased donors.1,2 Historically, living donor
nephrectomy (LDN) had been performed as an open technique, which brought significant comorbidity and impacted
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donor quality of life. Over the last two decades, surgical
practices have developed with the aim of improving postoperative donor recovery, while maintaining surgical quality;
these modifications to the donor operation have included
mini-incision muscle-splitting open LDN through a dorsal
lumbotomy,3 to minimally invasive techniques, including
standard laparoscopy,4 hand-assisted laparoscopy,5 and retroperitoneoscopy.6 The advent of laparoscopic LDN was not
only associated with a significant rise in the number of living donors globally, but also had a major impact on patient
satisfaction with the operation and improved post-surgical
recovery and pain scores. More recently, novel minimally
invasive techniques have been introduced, including laparoendoscopic single-site surgery (LESS),7 natural oriﬁce transluminal endoscopic surgery (NOTES)-assisted laparoscopy,8,9
mini-laparoscopy,10 and robot-assisted laparoscopy,11 all of
which have been applied to living donor surgery.
With surgical technologies advancing towards less invasive methods and with increasing pressure from patients to
incorporate these new techniques into practice, data has
emerged suggesting that single-incision surgery may be the
next major advance to the living donor operation. In a recent
systematic review and meta-analysis of over 1500 cases
comparing laparoscopic and LESS nephrectomy, Autorino
et al12-14 showed that LESS patients beneﬁted from decreased
postoperative pain, lower analgesic requirements, shorter
hospital stay, faster recovery time, and not surprisingly, a better cosmetic outcome. As we want to minimize the burden of
living donor surgery to the healthy, young, active individual,
the concept of minimizing the skin incision is appealing and
may further incentivize organ donation.
The learning curve of LESS donor nephrectomy procedure is notoriously steep, even in experienced centres. We
predicted that the use of robotic assistance would make a
significant impact on the learning curve of the LESS surgery,
as it offers a significant improvement in visualization and
intracorporeal maneuverability and dexterity. Therefore, we
hypothesized that robotic-assisted LESS living donor surgery
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(R-LESS) is feasible, with minimal impact on operative time
and complications. Furthermore, we evaluated whether
R-LESS has a positive impact on patient outcomes, pain,
and quality of life following living donation.

Methods
Between October 2013 and November 2015, 46 patients
underwent LDN at University Hospital, London Health
Sciences Centre, London, ON, Canada. Consecutive patients
were approached at the time of their first clinic assessment
to be entered into the prospective study (REB#101769). All
patients were consented to receive either standard laparoscopic donor nephrectomy or R-LESS nephrectomy; randomization was not possible, as access to the robot was
not predictable. All donor surgeries were performed by
two surgeons (Patrick Luke, Alp Sener). One surgeon had
experience with R-LESS pyeloplasty, nephrectomy, partial
nephrectomy, and adrenalectomy prior to performing donor
nephrectomy. The donors were slotted for a standing date; if
the robot was available that day, the patient was placed in
the R-LESS arm; if the robot was not available, the patient
was slotted for the LLDN arm of the study. Seven patients
decided not to participate. Patients underwent either standard laparoscopic living donor nephrectomy (LLDN) (n=25)
or R-LESS LDN (n=14). Donor and recipient demographic
characteristics were collected, including: age, gender, body
mass index (BMI), side of procedure, and number of renal
arteries. Perioperative outcomes between the two procedures
were compared using operative time, warm ischemia time
(WIT), estimated blood loss, hospital length of stay, analgesic
requirements (calculated in terms of hydromorphone equivalents), visual analogue scale15 of pain on postoperative days
1, 3, 7, and 30. Graft function based on serum creatinine
and modification of diet in renal disease (MDRD)-based
estimated glomerular filtration rate (eGFR) measurements on
day 3 and one year, and a health-related quality of life and
body image questionnaire16
were also performed on days
A
3, 7, and 30 post-donation.
Delayed graft function (DGF)
was defined as the need for
hemodialysis in the first week
following transplantation.
Postoperative complications
were graded according to the
Clavien-Dindo system.17

Donor nephrectomy surgical technique
Robot-assisted laparoendoscopic single-site technique
The da Vinci Si Surgical System (Intuitive Surgical, Sunnyvale
CA, U.S.) was used for all procedures. Patients were positioned in the right lateral decubitus position. A single incision was made through the umbilicus measuring approximately 4.0 cm in length and a GelPort (Applied Medical,
Rancho Santa Margarita, CA, U.S.) pre-punctured with four
trocars (camera port, two 8 mm robot working trocars, and a
10 mm accessory trocar) was placed through the umbilicus
(Fig. 1). Once the abdomen was insufflated, the daVinci
robot was docked behind the shoulder of the patient with
the first setup joint locked in a straight position in order
to facilitate proper insertion of the working instruments as
previously described (Fig. 2).18
The operation began with mobilization of the descending colon. The ureter was then identiﬁed and circumferentially dissected along the gonadal vein. Following the left
gonadal in the cephalad direction, the left renal vein was
subsequently identiﬁed. Gerota’s fascia was incised and the
kidney was separated from its attachments to the left adrenal
gland and the spleen. The renal vein was circumferentially
dissected. The gonadal vein was divided close to the renal
vein between clips. The left renal artery was circumferentially isolated to the level of its aortic takeoff. The robot was
then undocked and the ureter was divided using 10 mm
Hemolock clips. After replacing the 10 mm port with a 15
mm port (Ethicon Endosurgery, Cincinnati OH, U.S.), the
renal artery and vein sequentially controlled and stapled
using a 35 mm endovascular stapler (Ethicon, Cincinnati
OH, U.S.).
The kidney was then retrieved with a 15 cm Endocatch
bag (Ethicon Endosurgery, Cincinnati OH, U.S.) placed
through the 15 mm port and retrieved through the GelPort.
The kidney was immediately flushed with Custodiol HTK

B

Fig. 1. (A) Placement of inner phalange using GelPort device. (B) Disposable and 8 mm robotic ports placed through the
GelPort device.
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Fig. 2. (A) Positioning of the robot over the posterior shoulder of the patient for single-incision surgery. The patient is positioned at 45 degrees in the right lateral
oblique position. (B) The first setup joint is locked in a straight position to facilitate proper insertion of multiple working instruments in the umbilical port. Rendering
© Intuitive Surgical 2015 with permission.

solution (Odyssey pharmaceuticals Inc., Florham Park, NJ,
U.S.) containing 10 000 IU of heparin until the effluent was
clear and placed on ice until transplantation.

Standard multi-port LDN
A standard LDN was carried out in the usual fashion.18 Once
the patient was positioned in the manner described above, a
Hasson blunt tipped trochar was inserted under direct vision
just lateral and superior to the umbilicus; this was used as
the camera port. Once the abdomen was insufflated, a 5 mm
trochar below the costal margin and a 10–12 mm trochar
was inserted in the lower quadrant. Standard instruments
were used in all cases. At the point of organ extraction,
we made a Pfannenstiel incision and introduced a 15 mm
Endocatch bag for the retrieval, which was done in a similar
fashion as described above.
In both groups, WIT was defined as the time between
initial stapler application to the renal artery and hypothermic
organ perfusion with preservation solution.

Statistical analyses
Demographic characteristics, as well as perioperative and
postoperative outcomes were compared between each of
the two groups. Complications were classified according to
the Clavien-Dindo system. Internal reliability for each scale
was evaluated by Cronbach’s alpha. The Cronbach’s alpha
for the body image scale was 0.82 and Cronbach’s alpha for
the Cosmetic questionnaire was 0.76. These values suggest
that the scales showed good internal consistency. Mean scale
E442

scores for the of each scale at day 1, 3, 7, and 30 postoperatively were evaluated for significance of difference using
the non-parametric Wilcoxon signed-rank test for hypothesis
testing of repeated measurements. The categorical data for
assessing differences in both R-LESS LDN group and LLDN
group were analyzed using a paired Student’s t-test. Data
analyses were performed using SPSS version 22.0 (SPSS,
Inc. Chicago, IL, U.S.).

Results
The demographic characteristics, intraoperative and postoperative outcomes for patients in both cohorts are listed
in Tables 1 and 2. There were no significant differences in
intraoperative outcomes, including operative time between
LLDN and R-LESS LDN. Although there were no conversions of R-LESS to LLDN or open DN, the addition of a 5
mm port was required via the GelPort to facilitate R-LESS
in four cases where the spleen retraction was difficult. We
observed no DGF in both group and no statistical differences
in the mean serum creatinine of the recipients at one year
post-transplant. Mean creatinine of donors was equivalent
at day 3 in both cohorts. The R-LESS cohort had statistically
superior visual pain scores on day 1 and 3 (p<0.001) and the
mean hydromorphone equivalent analgesia needed in the
R-LESS cohort was 15.9±3.3 mg in first 48 hours after surgery
compared to 18.15±5.1 mg for the LLDN cohort (p=0.002).
In the R-LESS LDN group, one patient developed a retroperitoneal hematoma that was treated conservatively and
transfused with two units of packed red blood cells. In the
LLDN group, two patients developed abdominal wall hema-
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Table 1. Demographic characteristics
Type of donor surgery
Number of patients
Age, years (range)
Male: Female
BMI (kg/m )
Right: Left
Multiple arteries

Laparoscopic
25
50 (26–68)
7:18

R-LESS
14
51(41–64)
9:5

p
0.97
-

27.1±3.8
5:20
4

25.8±3.4
0:14
3

0.24
-

Data are presented as mean ± standard deviation. BMI: body mass index. R-LESS: robotic
laparoendoscopic single-site.

tomas (managed conservatively), two patients developed
neuromuscular pain with bilateral flank discomfort, and one
patient with a BMI of 38 developed a port site infection.
Overall, postoperative complication rates between the two
cohorts were low, with all complications classified as Grade
2 according to the Clavien-Dindo system.
All 14 patients who underwent R-LESS LDN and all 25
who underwent LLDN responded to The Body Image Scale,
Cosmesis Scale, and Visual Analog Pain Scale questionnaires. The responses are shown in Tables 3–7.

Body image and cosmesis following living donation
The first question asked of the donors was, “Are you less
satisfied with your body since the operation?” In the R-LESS
group, 92% of respondents reported complete satisfaction
by day 3, whereas only 50% of respondents in the laparoscopic group reported complete satisfaction by the third
day (p=0.002). Although this persisted up to seven days, by
postoperative day 30, both groups had similar satisfaction
scores (p=0.71) (Table 3). In response to second question,
“Do you think the operation has damaged your body?” on
days 3 and 7, patients undergoing R-LESS felt they had no or
little damage to their body compared to laparoscopic group
(p<0.001), but by day 30, both groups reported similar findings (p=0.51) (Table 4). The final question in the body image
index was, “Is it difficult to look at yourself naked as a result
of the operation?” Both groups reported similar responses
to this question at all-time points on postoperative days 3,
7 and 30, respectively (p=0.41) (Table 5). With respect to
cosmesis, patients were asked to rate their satisfaction with
their surgical scar on a scale from 1–7. Cosmetically, living
donors were more satisfied with their incisions in the R-LESS
group compared to the LLDN group across all time points
on postoperative days 3, 7, and 30. (p=0.008) (Table 6).

Table 2. Intraoperative and postoperative outcomes in
patients undergoing laparoscopic vs. robot-assisted LESS
donor nephrectomy
Type of donor surgery
Laparoscopic R-LESS
p
Number of patients
25
14
Operative time (min)
240±53
269±75
0.90
Estimated blood loss (mL)
103±70
140±59
0.24
Length of stay (days)
3.5± 0.86
3.1±0.70 0.81
WIT (min)
4.15±1.1
4.3±1.1
0.52
Total hydromorphone equivalent
18.15±5.1
15.9±3.3 0.002
(mg)
Serum creatinine (μmol/L, day 3)
96±10
95±15
0.51
Serum creatinine (μmol/L, 1
102±21
106±12
0.22
year)
eGFR (mL/min per 1.73 m2)
84±17.14
86±17.74 0.51
DGF
0
0
Complications: (Clavien-Dindo)
Hematoma requiring
0
1
transfusion
Abdominal wall hematoma no
1
0
transfusion
Neuromuscular pain
2
0
Port site infection
1
0
All complications classified as Grade 2 according to the Clavien-Dindo system. Data are
presented as mean ± standard deviation. DGF: delayed graft function; eGFR: estimated
glomerular filtration rate; R-LESS: robotic laparoendoscopic single-site; WIT: warm ischemic
time.

26% LLDN group) on day 1 and 3 (p<0.001); however, from
day 7 onwards, both groups showed similar perceptions of
pain and clinically not significant (p=0.16) (Table 7).

Discussion
With the increasing number of patients requiring kidney
transplantation, multiple strategies to increase the number of
donors, including laparoscopic living donation, have been
developed. Advancements in laparoscopy have led to the
Table 3. Body image scale – Are you less satisfied with your
body since the operation?
Postoperative day
LESS robotic

Laparoscopic

Visual analog pain score
Living donors from each cohort were asked how they rated
their pain on a visual analog pain scale from 1–10 on postoperative days 1, 3, 7, and 30. The R-LESS cohort had statistically superior pain scores (none/mild pain R-LESS 50% vs.

Yes, extremely
Quite a bit
A little bit
No, not at all
Yes, extremely
Quite a bit
A little bit
No, not at all

3
0%
0%
8%
92%
0%
0%
50%
50%

7
0%
8%
34%
58%
4%
4%
35%
57%

30
8%
0%
34%
58%
0%
0%
26%
74%

R-LESS group, 92% of respondents reported complete satisfaction by day 3, whereas only
50% of respondents in the LLDN group reported complete satisfaction by the third day
(p=0.002), but by day 7 and 30, both groups had similar satisfaction scores (p=0.71). LLDN:
laparoscopic living donor nephrectomy; R-LESS: robotic laparoendoscopic single-site.
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Table 4. Body image scale – Do you think the operation has
damaged your body?

Table 5. Body image scale – Is it difficult to look at yourself
naked as a result of the operation?

Postoperative day
LESS robotic

Laparoscopic

Yes, extremely
Quite a bit
A little bit
No, not at all
Yes, extremely
Quite a bit
A little bit
No, not at all

3
0%
0%
33%
67%
0%
13%
48%
39%

7
0%
0%
42%
58%
0%
0%
46%
54%

Postoperative day
30
0%
0%
36%
64%
0%
0%
30%
70%

R-LESS group reported no perception of damage to their body on day 3 and 7 compared
to LLDN group (p=0.001); however, by day 30, both groups reported similar perception
(p=0.51). LLDN: laparoscopic living donor nephrectomy; R-LESS: robotic laparoendoscopic
single-site.

use of LESS surgery in living donation; unfortunately, the
ergonomics of single-port surgery lends itself to a very steep
learning curve. The current study was designed to evaluate whether a single-incision robotic platform would allow
surgeons to make the leap to single-incision living donor
surgery. We are the first to demonstrate that there were no
significant differences in intraoperative outcomes between
LLDN and R-LESS-LDN cohorts. Analysis showed statistically
differences in visual analogue pain scores on days 1 and 3
(p<0.001) between the R-LESS LDN and LLDN cohorts, however, from day 7 onwards, both groups showed similar and
clinically non-significant perceptions of pain (p=0.16). In
addition, the analgesic requirements were lower for R-LESS
cohort (p=0.002) immediately after surgery. They demonstrate earlier improvement in the donor body image and
patients in the R-LESS LDN cohort had a higher satisfaction
score compared to the LLDN cohort (p=0.008). There were
no significant differences in the postoperative complication
rates in either cohort.
Table 6. Cosmesis scale – On a scale of 1–7, how satisfied
are you with your scar?
Postoperative day
LESS robotic

Laparoscopic

1, Very unsatisfied
2
3
4
5
6
7, Very satisfied
1, Very unsatisfied
2
3
4
5
6
7, Very satisfied

3
0%
0%
0%
0%
23%
23%
54%
0%
0%
4%
31%
11%
27%
27%

7
8%
0%
0%
17%
17%
8%
50%
0%
12%
4%
24%
24%
0%
36%

30
9%
0%
9%
9%
18%
0%
55%
4%
0%
0%
13%
17%
31%
35%

R-LESS group were more satisfied with the cosmetic outcome of the surgery compared
to the LLDN group on postoperative days 3, 7, and 30 (p=0.008). LLDN: laparoscopic living
donor nephrectomy; R-LESS: robotic laparoendoscopic single-site.

E444

LESS robotic

Laparoscopic

Yes, extremely
Quite a bit
A little bit
No, not at all
Yes, extremely
Quite a bit
A little bit
No, not at all

3
0%
0%
18%
82%
0%
4%
7%
89%

7
0%
4%
7%
89%
0%
0%
8%
92%

30
0%
0%
0%
100%
0%
0%
13%
87%

Both groups reported similar responses to this question at all-time points on postoperative
days 3, 7, and 30, respectively (p=0.41). LESS: laparoendoscopic single-site.

Gill et al7 first reported the successful completion of four
single-port transumbilical LDNs. Soon after, the same group
reported the first retrospective matched-pair comparison
of LESS LDN to standard LDN, concluding that the LESS
approach may be associated with quicker convalescence
and comparable early allograft outcomes.19 Since then,
other groups have reported comparative assessments of the
two LDN approaches, with conflicting findings.20-22 When
adopting a novel surgical technique, patient safety represents a key factor and this is especially true in the case
of a LDN. As a general principle, all eligible laparoscopic
surgery patients may be considered for LESS. At the same
time, patient selection with LESS must be more rigorous to
minimize the surgical risk.
In our study, we found no significant differences in total
operating time between R-LESS LDN, including robot setup
time compared with LLDN (p=0.90). Operating time is
routinely considered a parameter to estimate the surgical
learning curve. In this regard, Stamatakis et al23 observed
a little change over the course of their series, suggesting a
very shallow learning curve and that for a surgeon already
experienced with LDN, LESS LDN case numbers might not
be as important in determining operating times after a plateau has been reached. Both surgeons in our cohort have
extensive expertise in laparoscopic surgery, with one having
experience in R-LESS surgery, mainly with pyeloplasty.18 The
Table 7. Visual analog pain scale
Postoperative day
LESS robotic

Laparoscopic

None (0)
Mild (1–3)
Moderate (4–6)
Severe (7–10)
None (0)
Mild (1–3)
Moderate (4–6)
Severe (7–10)

1

3

7

30

7%
43%
35%
14%
4%
22%
52%
22%

7%
43%
33%
14%
0%
59%
26%
15%

50%
41%
8%
0%
38%
47%
15%
0%

67%
33%
0%
0%
64%
36%
0%
0%

R-LESS group reported lower pain scores (none/mild pain R-LESS 50% vs. 26% LLDN
group) on day 1 and 3 (p<0.001); however, from day 7 onwards, both groups showed
similar perceptions of pain (p=0.16). LLDN: laparoscopic living donor nephrectomy; R-LESS:
robotic laparoendoscopic single-site.
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experience provided safety for donor, but limiting ability to
assess learning curve for R-LESS.
WIT is traditionally recognized as a surrogate measure of
surgical quality during LDN.24 We did not find a significant
difference in WIT between the two cohorts (p=0.52). In their
comparative studies, Canes et al19 found WIT to be twice
as long in the LESS LDN group, and most of this extra time
was spent creating an adequate fascial incision, as this site
was not prepared before extraction. In contrast, Stamatakis
et al23 were the first to document a statistically significant
decrease (0.5 minutes) in WIT with LESS LDN as compared
with LDN. The authors attributed this finding to the use of
the GelPoint™, eliminating the need to complete an incision
after transection of the renal vasculature. Our technique of
using the GelPort for access allowed for a larger facial incision, which enabled quick extraction of the kidney while still
maintaining a smaller skin incision through the umbilicus.
More clinically relevant than WIT is graft function, which
was assessed only in few of the studies by using creatinine
levels.19,20 In the present study, we demonstrate that serum
creatinine and eGFR levels were similar between the two
groups (p=0.51), even at one year post-transplant. In addition, we found no DGF in either group, which is a strong
predictor of early graft injury and poor longer-term function,25 thus further supporting that the R-LESS approach to
living donation does not compromise graft outcomes.
It is a well-established principle that single renal artery
left kidneys are preferred by most transplant surgeons due
to the longer length of the left renal vein compared with
the right renal vein. In the present study, all of the R-LESS
group had left-sided nephrectomies. We did not exclude
right donor nephrectomy intentionally. More importantly,
we had selected the left side despite supernumery arteries
even before the case was assigned to the R-LESS cohort,
suggesting that multiple vessels can also be handled with
the R-LESS approach and that these patients should not be
excluded. In other reported studies, some investigators considered only left-sided donors19,21 and non-complex vasculature21,26 as inclusion criteria for LESS donation, whereas
others did not.20,21 As excellent long-term outcomes can
be obtained with LDN with right and/or complex vascular
anatomy requiring reconstruction, the presence of multiple
renal arteries should ideally not preclude R-LESS kidney
donation,25 at least in experienced centThe rationale behind
the adoption of LESS is mainly based on the potential gain
for the patient in terms of lower postoperative pain, shorter
hospital stay, and ultimately faster recovery. Length of stay
represents an unreliable endpoint in this patient population,
as donors may express the desire to remain in the hospital
longer because of psychosocial considerations.12 In the present study, analysis showed statistically differences in visual
analogue pain scores on day 1 and 3 (p<0.001) between
the R-LESS LDN and LLDN cohorts, as well as in analgesic

requirements; however, from day 7 onwards, both groups
showed similar and clinically non-significant perceptions of
pain (p=0.16). They demonstrate earlier improvement in the
donor body image and the R-LESS LDN cohort had a high
satisfaction score compared to the LLDN cohort (p=0.008).
However, there was no significant difference of the hospital stay between R-LESS LDN and with LLDN (p=0.81). In
keeping with our findings, Fan et al12 also reported reduced
postoperative pain and lower analgesic requirement for LESS
nephrectomy procedures. This is in congruence with what
we observed and is expected with smaller total length of
incisions in the R-LESS cohort.
Complication rates are broadly considered surrogate
markers for surgical complexity. Accurate reporting of complications is important for preoperative counselling and for
identifying modifiable risk factors to decrease complication
rates. Greco et al27 investigated risk factors for complications in a multi-institutional series of LESS surgery for a
range of upper urinary tract disease and found an overall
complication rate of 17%. In a larger analysis of surgical
outcomes from LESS cases of mixed indications, Autorino
et al28 reported a 9.4% postoperative overall complication
rate, most of them being of low Calvien grade. In the present analysis, we did not find any significant difference in
terms of postoperative complication rates between the two
cohorts, with all complications being Grade 2 according to
the Clavien-Dindo classification.
Although not randomized, this is the first detailed prospective assessment of the R-LESS technique in performing
LDN. Although our numbers are small, we publish these
results as an indicator of quality for our novel technique and
demonstrate modest but significant benefits in this population of young, healthy patients, who may engender benefit
from a cosmetically superior operation. A limitation was
that we were not able to blind the patients immediately
preoperatively or postoperatively (with abdominal binders
to mask the scars); this may be what is needed to truly create a randomized trial in the future. However, we did not
emphasize that one technique was more beneficial than
the other during the consent process, so as to minimize
patient bias. It has been our hope that the minimally invasive nature of this technique would increase the appetite
for healthy, active individuals to participate in living donation. In fact, it is of interest that the availability of R-LESS
technique has been associated with an increased interest
in living donation by potential donor patients at our institution. Furthermore, we hope that our excellent preliminary
results will encourage other groups to assess R-LESS donor
nephrectomy as a part of multicentred, prospective study
to firmly establish the procedure as a reasonable option
for donor nephrectomy. With the advancement of robotic
platforms intended for single-incision surgery by companies such as Titan MedicalTM and Intuitive Surgical®, the
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role of robotic surgery in donor nephrectomy should be
re-assessed on a continuous basis.

Conclusion
These are the first reported results demonstrating that R-LESS
LDN procedure offers comparable surgical and early functional outcomes compared to standard LDN but with reduced
postoperative pain, improved body image scores, and overall satisfaction with the donation process. R-LESS is more
technically challenging than standard LLDN counterpart.
However, with increasing level of expertise in users across
many centres and the continually advancing technology
in robotics, this novel approach should be compared with
standard LLDN in a well-designed, large, prospective, randomized, ulticenter study before gaining wider acceptance.
Competing interests: Dr. Sener has received grants/honoraria from CONMED, Eli Lilly, and FirstKIND;
and is the co-founder of Clearwater Clinical Limited. The remaining authors report no competing
personal or financial interests.
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